Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02058836 · ClinicalTrials.gov registry record · Phase 2
Botulinum Toxin for the Management of Chronic Orchialgia
A Phase 2 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT02058836 is a Phase 2 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 8 participants.
The verdict
NCT02058836, a Phase 2 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine if Botox injections will provide relief from chronic testicular pain. In the study, the spermatic cord of particpants will be injected with either Botox or a placebo of saline. Botox is currently used to treat other urological conditions like overactive bladder and lower urinary tract problems. For these conditions, Botox works by relaxing muscles in the affected areas. The investigators believe that Botox will act similarly in the treatment chronic testicular pain.
Interventions
- DRUG Botox Injection
- PROCEDURE Normal saline injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2014-11 |
| Est. Completion | 2016-10-18 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02058836
The ClinicalTrials.gov registry entry for NCT02058836 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Botox Injection is the first listed.
NCT02058836 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02058836 about?
NCT02058836 is a clinical study titled "Botulinum Toxin for the Management of Chronic Orchialgia". The purpose of this research study is to determine if Botox injections will provide relief from chronic testicular pain. In the study, the spermatic cord of particpants will be injected with either Botox or a placebo of saline. Botox is currently used to treat other urological conditions like overac...
What is the current status of trial NCT02058836?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2014-11. Estimated completion is 2016-10-18.
What interventions are being tested in trial NCT02058836?
The interventions under investigation include: Botox Injection (DRUG), Normal saline injection (PROCEDURE).
Who is sponsoring clinical trial NCT02058836?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.